Graincide Tablet SR
Marketer
Synovia Life Sciences Pvt Ltd
Salt Composition
Propranolol (40mg) + Flunarizine (10mg)
Overview Graincide Tablet SR
MigraGuard SR tablets combine two active ingredients to prevent migraine episodes. This medication is not intended for treating acute migraine attacks. MigraGuard SR should be taken on an empty stomach, consistently at the same time each day, ideally at night. Dosage frequency is determined by your individual needs and will be prescribed by your physician to optimize symptom management. Continue taking this medication for the duration specified by your doctor. Lifestyle adjustments such as stress reduction, smoking cessation, and limiting processed foods may enhance its effectiveness. Potential side effects include weight increase, bradycardia, fatigue, depression, somnolence, and cold extremities. Due to potential drowsiness, avoid driving or activities requiring alertness; rise slowly from a seated position. This medication can mask hypoglycemic symptoms; therefore, regular blood glucose and blood pressure monitoring are essential. Before commencing treatment, inform your doctor about any liver or kidney disease, depression, pregnancy, breastfeeding, or other medications you are currently using, as interactions may reduce efficacy or alter the drug's effects.
Uses of Graincide Tablet SR
Migraine Prevention Strategies
Major Benefits of Graincide Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; do not crush, chew, or fracture it. Administer Graincide Tablet SR on an empty stomach.
Common Side effects of Graincide Tablet SR:
- Weight gain
- Slow heart rate
- Tiredness
- Depression
- Drowsiness
- Abnormal dreams
- Cold extremities
How to use Graincide Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Graincide SR Tablets. Ingest the tablet whole; do not crush, chew, or fracture it. Administer this medication on an empty stomach.
How Graincide Tablet SR works:
Graincide SR tablets contain propranolol, a beta-blocker, and flunarizine, a calcium channel blocker, acting synergistically to prevent migraine attacks. This combination stabilizes overactive nerve cells, raising the threshold for migraine initiation. Additionally, it suppresses cortical spreading depression, the electrical brainwave activity responsible for migraine pain and inflammation.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Graincide Tablet SR should not be taken together.
PregnancyCONSULT YOUR DOCTOR
The extended-release Graincide Tablet might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Graincide Tablet SR with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release Graincide tablets can induce adverse reactions that might impair driving capabilities. These reactions may include blurred vision, hallucinations, drowsiness, cognitive impairment, vertigo, or lethargy, all potentially impacting safe driving.
KidneySAFE IF PRESCRIBED
Extended-release Graincide tablets are likely safe for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Graincide Tablet SR; dosage modification may be necessary. Physician consultation is recommended. Routine blood pressure monitoring is suggested to guide dosage alterations.
What if you forget to take Graincide Tablet SR :
Should you forget a Graincide Tablet SR dose, take it immediately. If, however, your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Graincide Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |


